News & Perspective

Jan 18, 2019

Jan 18, 2019
Plasmodium in bloodstream

New one-dose drug prevents malaria relapse, studies show

A total of 62.4% of patients taking tafenoquine were free of P vivax after 6 months.

Feb 01, 2019

Feb 01, 2019

ASP Scan (Weekly) for Feb 01, 2019

Animal stewardship partnership
Antibiotic pipeline details
New PACCARB members
Decline in UK antibiotics
Superbug bloodstream infections in Greece
Antibiotics and malaria prevention
Promising antifungal candidate
Proposed UN AMR guidance
Proposed UN AMR guidance
Antibiotic use in nursing homes
Novel antibiotic vs C diff
Pharmacist interventions
Antibiotics for asthma attack

Feb 08, 2019

Feb 08, 2019
Pneumonia xray

Omadacycline trials show efficacy for pneumonia, skin infections

The new drug is a 'modernized' version of tetracycline, designed to address antibiotic resistance, but its clinical role isn't yet clear.

Feb 08, 2019

ASP Scan (Weekly) for Feb 08, 2019

Inadequate TB drug-susceptibility testing
New UK guidance on antibiotics for acute cough
FDA to review new Merck antibiotics
CARB-X novel antibiotic funding
Antibiotic prescribing intervention in China
Candida auris fungemia
Microbiology test use in Norway
CRP-guided therapy
Formulary restriction policy
New CARB-X funding
Feb 08, 2019

Stewardship / Resistance Scan for Feb 08, 2019

Inadequate TB drug-susceptibility testing
New UK guidance on antibiotics for acute cough

Mar 07, 2019

Mar 07, 2019

News Scan for Mar 07, 2019

Saudi MERS cases
Yellow fever in South America
Absenteeism and illness
Flu vaccine and heart attack

May 03, 2019

May 03, 2019

News Scan for May 03, 2019

WHO H5N1 flu confirmation
Carbapenem reduction strategy
More polio in Afghanistan, Pakistan
Flu imprinting research
Mayaro virus in South America

Jun 20, 2019

Jun 20, 2019

News Scan for Jun 20, 2019

Saudi MERS case
US flu season severity
Guillain-Barre in Peru

by country

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»